
Novartis AG: updates and filings
Price
$155.21
November 18, 2026Market cap $296B
What Ploutos Investor adds for Novartis
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from 2016
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 12, 2026Current report (foreign company)Form6-K
- Oct 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 27, 2026Current report (foreign company)Form6-K
- Sep 8, 2026Current report (foreign company)Form6-K
- Sep 4, 2026Current report (foreign company)Form6-K
- Sep 1, 2026Current report (foreign company)Form6-K
- Jul 21, 2026Current report (foreign company)Form6-K
- Jun 11, 2026Current report (foreign company)Form6-K
- Apr 28, 2026Current report (foreign company)Form6-K
- Mar 18, 2026Current report (foreign company)Form6-K
- Feb 4, 2026Shares registered for employeesFormS-8
- Feb 4, 2026Current report (foreign company)Form6-K
- Feb 4, 2026Current report (foreign company)Form6-K
- Feb 4, 2026FilingFormIRANNOTICE
- Feb 4, 2026Annual report (foreign company)for the period to Dec 31, 2025Form20-F
- Jan 16, 2026FilingFormS-8 POS
- Jan 16, 2026FilingFormS-8 POS
- Jan 16, 2026FilingFormS-8 POS
- Jan 16, 2026FilingFormS-8 POS
- Jan 14, 2026FilingFormDFAN14A
- Jan 12, 2026FilingFormDFAN14A
- Nov 25, 2025Current report (foreign company)Form6-K
- Nov 20, 2025Current report (foreign company)Form6-K
- Nov 5, 2025Current report (foreign company)Form6-K
- Oct 28, 2025FilingFormDFAN14A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 12, 2026 | 6-K | Current report (foreign company) | Document |
| Oct 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 27, 2026 | 6-K | Current report (foreign company) | Document |
| Sep 8, 2026 | 6-K | Current report (foreign company) | Document |
| Sep 4, 2026 | 6-K | Current report (foreign company) | Document |
| Sep 1, 2026 | 6-K | Current report (foreign company) | Document |
| Jul 21, 2026 | 6-K | Current report (foreign company) | Document |
| Jun 11, 2026 | 6-K | Current report (foreign company) | Document |
| Apr 28, 2026 | 6-K | Current report (foreign company) | Document |
| Mar 18, 2026 | 6-K | Current report (foreign company) | Document |
| Feb 4, 2026 | S-8 | Shares registered for employees | Document |
| Feb 4, 2026 | 6-K | Current report (foreign company) | Document |
| Feb 4, 2026 | 6-K | Current report (foreign company) | Document |
| Feb 4, 2026 | IRANNOTICE | Filing | Document |
| Feb 4, 2026 | 20-F | Annual report (foreign company)for the period to Dec 31, 2025 | Document |
| Jan 16, 2026 | S-8 POS | Filing | Document |
| Jan 16, 2026 | S-8 POS | Filing | Document |
| Jan 16, 2026 | S-8 POS | Filing | Document |
| Jan 16, 2026 | S-8 POS | Filing | Document |
| Jan 14, 2026 | DFAN14A | Filing | Document |
| Jan 12, 2026 | DFAN14A | Filing | Document |
| Nov 25, 2025 | 6-K | Current report (foreign company) | Document |
| Nov 20, 2025 | 6-K | Current report (foreign company) | Document |
| Nov 5, 2025 | 6-K | Current report (foreign company) | Document |
| Oct 28, 2025 | DFAN14A | Filing | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Apr 11, 2001.
The full analysis
What do Novartis's filings show?
The filings are where every one of Novartis's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.